← All stocks

Fulcrum Therapeutics, Inc.

FULC Net selling

CIK 0001680581 #3613 in the set updated 17 Sep 2026

Bought (12 mo)

$1.49M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$58.99M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$58.99M

8 of 8 sales

Net

−$57.51M

−$57.51M against sales at will

By person

6 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

RA CAPITAL MANAGEMENT, L.P. entity

10% owner

—

$58.38M (3)

−$58.38M

6,053,960

7.93%

$21.31M

−40.8%

TANG KEVIN

10% owner

$1.49M (6)

—

+$1.49M

7,080,945

9.28%

$24.92M

+6.3%

Gould Robert J

Director

—

$504.44K (3)

−$504.44K

454,864

0.5962%

$1.60M

−9.0%

Ezekowitz Alan

Director

—

$65.61K (1)

−$65.61K

10,927

0.0143%

$38.46K

−62.2%

Oltmans Curtis Gale

Chief Legal Officer

—

$44.60K (1)

−$44.60K

10,252

0.0134%

$36.09K

−25.2%

Tourangeau Greg

Principal Accounting Officer

—

14,062

0.0184%

$49.50K

−3.4%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 21

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 3

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 8

Transactions with no price 0

Shares from compensation/vesting 0

History held since 18 Jul 2019